MoneyWorks4Me

Dr. Reddy's Lab gets EIR for API manufacturing plant 5

11 Apr 2020 Evaluate

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA), for its API manufacturing plant 5 at Miryalaguda, Nalgonda district, Telangana, indicating closure of the audit and the inspection classification of this facility is determined as Voluntary Action Indicated (VAI).

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..